Trials Continue

PharmAust shares soar following promising COVID-19 treatment results

Finfeed Archived Jun 04, 2020

PharmAust's (ASX:PAA) demonstrates both infectivity and replication of SARS-CoV-2 virus particles can be suppressed in cell cultures.